Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

The Fall 2022 edition of the CBS Newsletter has been released. You can access it here.

The 38th CBS annual meeting with be held at Dalhousie University in Halifax, Nova Scotia. Call for abstracts opens December 1st, 2022, and the Early Bird registration deadline is March 1st, 2023...

The Canadian Biomaterials Society is pleased to present The 2022-2023 CBS mentorship and Professional Development Program Join The 2nd Lab and the CBS-QC Student Chapter this Friday, October 7th, 2022 at 5 00 PM for a hybrid information session about this program...

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Joint replacement provides pain relief and restores joint function to patients suffering from problems - namely arthritis...

Acute myeloid leukemia AML is a highly heterogeneous disease with considerable diversity in molecular pathogenesis and clinical outcomes...

Post transcriptional silencing of aberrant genes with the delivery of short interfering RNA siRNA has been a potent approach to cancer therapy over the last decade...

Craniomaxillofacial CMF trauma and disease often require surgical intervention to restore bone alignment and enable successful bone union...

Systemic adoptive T lymphocyte transfer is an emerging cancer immunotherapy showing tremendous promise in clinical studies, and its success lies in the ability of the antigen-experienced cytotoxic T lymphocytes cTL to access and to persist in the tumour microenvironment 1 ...